Valuation: ETHZilla Corporation

Capitalization 225M 193M 181M 169M 311M 20.22B 339M 2.11B 817M 9.56B 844M 826M 34.93B P/E ratio 2023
-0.08x
P/E ratio 2024 -0.12x
Enterprise value 220M 189M 177M 165M 305M 19.82B 332M 2.07B 801M 9.37B 827M 810M 34.24B EV / Sales 2023
-
EV / Sales 2024 -
Free-Float
59.53%
Yield 2023 *
-
Yield 2024 -
More valuation ratios * Estimated data
Dynamic Chart
1 day-10.86%
1 week-1.04%
Current month-1.59%
1 month-31.64%
3 months-56.57%
6 months-1.70%
Current year-42.25%
More quotes
1 week 9.33
Extreme 9.3295
11.82
1 month 9.33
Extreme 9.3295
19.08
Current year 6.58
Extreme 6.578
174.6
1 year 6.58
Extreme 6.578
174.6
3 years 6.58
Extreme 6.578
1,520
5 years 6.58
Extreme 6.578
49,572.12
10 years 6.58
Extreme 6.578
49,572.12
More quotes
Manager TitleAgeSince
Chief Executive Officer 46 03/09/2025
Investor Relations Contact 57 15/10/2025
Director TitleAgeSince
Director/Board Member 42 06/03/2024
Director/Board Member 54 03/08/2025
Director/Board Member 47 03/08/2025
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-10.86%-1.04%-52.87%-99.33% 252M
-0.29%+8.55%+30.94%+77.16% 3.17B
+1.91%+0.14%-12.14%-4.53% 2.13B
+3.46%+5.40%+51.24%+130.44% 1.74B
+3.18%+1.78% - - 1.37B
0.00%-11.54%-26.98%-25.81% 89.73M
0.00%-2.90%+55.81%+168.00% 62.02M
-0.43%+16.29%-97.19%-99.94% 50.18M
Average -0.38%+3.81%-7.31%+20.86% 1.11B
Weighted average by Cap. +1.21%+4.94%+19.21%+58.63%
See all sector performances

Financials

2023 2024
Net sales - -
Net income -19.94M -17.13M -16.04M -14.96M -27.54M -1.79B -30.04M -187M -72.41M -848M -74.81M -73.21M -3.1B -6.17M -5.3M -4.96M -4.63M -8.52M -554M -9.29M -57.94M -22.41M -262M -23.15M -22.65M -958M
Net Debt -922K -792K -742K -692K -1.27M -82.86M -1.39M -8.66M -3.35M -39.19M -3.46M -3.39M -143M -4.43M -3.81M -3.56M -3.32M -6.12M -398M -6.68M -41.62M -16.09M -188M -16.63M -16.27M -688M
More financial data * Estimated data
Logo ETHZilla Corporation
180 Life Sciences Corp. is focused on developing new technologies across multiple sectors. The Company is focused on iGaming sector, through its iGaming Technology Platform. The Company also continues to evaluate monetization strategies for its biotechnology assets.
Employees
4
More about the company
Date Price Change Volume
05/12/25 10.51 $ -10.86% 955,119
04/12/25 11.79 $ +4.06% 547,313
03/12/25 11.33 $ +6.48% 740,543
02/12/25 10.64 $ +12.35% 1,721,131
01/12/25 9.470 $ -11.33% 1,418,496

Delayed Quote Nasdaq, December 05, 2025 at 09:00 pm

More quotes

Annual profits - Rate of surprise